Progression and regression of coronary atherosclerosis: relation to risk factors.

[1]  R. Sannerstedt,et al.  ANALYSIS OF MORTALITY AND SURVIVAL IN ACTIVELY TREATED HYPERTENSIVE DISEASE. , 2009, Acta medica Scandinavica.

[2]  K. König,et al.  Secondary prevention in myocardial infarction survivors , 1981, Circulation.

[3]  L. Elveback,et al.  The unpredictable progression of symptomatic coronary artery disease: a serial clinical-angiographic analysis. , 1981, Mayo Clinic proceedings.

[4]  J. Kramer,et al.  Progression of Coronary Atherosclerosis , 1981, Circulation.

[5]  A. Bruschke,et al.  The Anatomic Evolution of Coronary Artery Disease Demonstrated by Coronary Arteriography in 256 Nonoperated Patients , 1981, Circulation.

[6]  W. Raynor,et al.  Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. , 1981, The New England journal of medicine.

[7]  W. Kostuk,et al.  Noninvasive and invasive demonstration of spontaneous regression of coronary artery disease. , 1980, Circulation.

[8]  A. Bruschke,et al.  Clinical Course of Patients with Normal or Slightly or Moderately Abnormal Coronary Arteriograms: 10‐year Follow‐up of 521 Patients , 1980, Circulation.

[9]  H. Gohlke,et al.  Progression and regression of coronary artery disease in postinfarction patients less than 40 years of age , 1980 .

[10]  C. Seltzer.  Smoking and coronary heart disease: what are we to believe? , 1980, American heart journal.

[11]  B. Ransil,et al.  Evolution of Left Ventricular Dysfunction in Coronary Artery Disease: Serial Cineangiographic Studies Without Surgery , 1980, Circulation.

[12]  M. Sanmarco,et al.  Angiography for study of lipid-lowering therapy. , 1979, Circulation.

[13]  J. Kostis,et al.  Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia. , 1979, Circulation.

[14]  P J Hamilton,et al.  A randomised controlled trial of the effect on middle-aged men of advice to stop smoking. , 1978, Journal of epidemiology and community health.

[15]  S H Brooks,et al.  Reproducibility of a consensus panel in the interpretation of coronary angiograms. , 1978, American heart journal.

[16]  K. G. Alberti,et al.  Severe diabetic ketoacidosis. , 1978, The Medical clinics of North America.

[17]  A. Bruschke,et al.  Natural history of obstructive coronary artery disease: ten-year study of 601 nonsurgical cases. , 1978, Progress in cardiovascular diseases.

[18]  A. Bruschke,et al.  Regression of coronary artery obstructions demonstrated by coronary arteriography. , 1976, European journal of cardiology.

[19]  W. Kannel,et al.  A general cardiovascular risk profile: the Framingham Study. , 1976, The American journal of cardiology.

[20]  S. Syme,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. , 1975, American journal of epidemiology.

[21]  R. Brand,et al.  Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. , 1975, JAMA.

[22]  C. Seltzer.  Smoking and coronary heart disease in the elderly , 1975, The American journal of the medical sciences.

[23]  L. Wilhelmsen,et al.  Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. , 1975, The American journal of cardiology.

[24]  L. Wilhelmsen,et al.  SMOKING AND MYOCARDIAL INFARCTION , 1975, The Lancet.

[25]  J. Stamler.  Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[26]  J. Parker,et al.  Prognosis in Coronary Artery Disease: Angiographic, Hemodynamic, and Clinical Factors , 1975, Circulation.

[27]  W. Kannel,et al.  Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.

[28]  R. Hone,et al.  Letter: Methicillin-resistant Staphylococcus aureus. , 1974, Lancet.

[29]  L. Kuller,et al.  Natural History of Ischemic Heart Disease in Relation to Arteriographic Findings: A Twelve Year Study of 224 Patients , 1974, Circulation.

[30]  L. T. Sheffield,et al.  Natural history of angina pectoris. , 1974, The American journal of cardiology.

[31]  J. Stamler.  The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. , 1972, JAMA.

[32]  Hames Cg.  Evans County cardiovascular and cerebrovascular epidemiologic study. Introduction. , 1971 .

[33]  A. Keys.  CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[34]  M. García-palmieri,et al.  Risk Factors and Prevalence of Coronary Heart Disease in Puerto Rico , 1970 .

[35]  F. Epstein,et al.  Overweight and Hypertension: A Review , 1969, Circulation.

[36]  Stephen J. Zyzanski,et al.  Cigarette Smoking: Its Relationship to Coronary Heart Disease and Related Risk Factors in the Western Collaborative Group Study , 1968, Circulation.

[37]  F. Smirk,et al.  The effect of drug treatment of hypertension on the distribution of deaths from various causes , 1967 .

[38]  F. Epstein,et al.  EPIDEMIOLOGICAL STUDIES OF CARDIOVASCULAR DISEASE IN A TOTAL COMMUNITY--TECUMSEH, MICHIGAN. , 1965, Annals of internal medicine.

[39]  R. Doll,et al.  Mortality in Relation to Smoking: Ten Years' Observations of British Doctors , 1964, British medical journal.

[40]  A. Bloom,et al.  Prolonged Coma in Simmonds's Disease , 1955, British medical journal.

[41]  K. M. West.  Epidemiology of diabetes and its vascular lesions , 1978 .

[42]  E. Freis.  Hypertension. A challenge in preventive cardiology. , 1973, Circulation.

[43]  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.

[44]  C. Jenkins,et al.  Coronary heart disease in the Western collaborative group study. A follow-up experience of two years. , 1966, JAMA.